Arctic Bioscience AS banner

Company Overview

Business Description

Sector
Health Care
Industry
Biotechnology
Headquarters
Norway NO
IPO date
Feb 24, 2021

Arctic Bioscience AS engages in the development, manufacturing, and marketing of marine ingredients extracted from herring roe. The company is headquartered in Orsta, More Og Romsdal. The company went IPO on 2021-02-24. Arctic Bioscience’s purpose is to provide people with autoimmune disorders an effective and healthy therapy based on marine membrane lipids. The firm is developing HRO350 - a novel investigational drug candidate. HRO350 is being developed for treatment of patients with mild-to-moderate psoriasis. The firm's product portfolio includes, among others, Romega, which is a producer of an omega-3 dietary supplement made from herring roe in a form of a capsule, as well as herring caviar oil and herring caviar protein offered to Business-to-Business (B2B) customers. Arctic Bioscience AS has three subsidiaries Arctic Nutrition AS, Romega AS and Arctic Biopharma AS.

Arctic Bioscience AS Investor Relations

Address
Industrivegen 42
Orsta, More Og Romsdal
Norway

Management

Mr. Harald Nordal M.B.A., M.Sc., MBA, MSc

Co-Founder & Chairman

Biography unavailable

Mr. Christer L. Valderhaug

Chief Executive Officer

Biography unavailable

Mr. Hogne Hallaraker

Founder & Chief Scientific Officer

Biography unavailable

Mr. Jone R. Slinning

Chief Financial Officer

Biography unavailable

Mr. Per Christian Sæbo

Chief Operating Officer

Biography unavailable

Mr. Daniele Mancinelli

Chief Technical Officer

Biography unavailable

Mr. Steffen Erland Eidal

Senior Vice President of Sales & Marketing

Biography unavailable

Dr. Yuming Feng

Executive Vice President of Global Business Development

Biography unavailable

Dr. Runhild Gammelsæter

Global Medical Director

Biography unavailable

1 / 9